Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

NOT YET RECRUITING

NCT07089355

Study Evaluating Toro 88 Super Bore Aspiration Catheter for Acute Ischemic Stroke

Sponsor: Toro Neurovascular, Inc.

View on ClinicalTrials.gov

Summary

The goal of this pilot study is to evaluate the safety and efficacy of the Toro 88 Super Bore Aspiration Catheter in acute ischemic stroke patients.

Official title: Open-Label, Single-Arm Study Evaluating Toro 88 Super Bore Aspiration Catheter Safety and Efficacy in Mechanical Thrombectomy for Acute Ischemic Stroke in France

Key Details

Gender

All

Age Range

18 Years - 90 Years

Study Type

INTERVENTIONAL

Enrollment

Start Date

2025-07

Completion Date

2026-03

Last Updated

2025-07-28

Healthy Volunteers

Conditions

Acute Ischemic Stroke

Interventions

DEVICE

Toro 88 Super Bore Aspiration Catheter

The Toro 88 Super Bore Aspiration Catheter is a neurovascular device designed for clot aspiration during mechanical thrombectomy procedures.

Inclusion Criteria: * Patients aged ≥ 18 and ≤ 90 years at the time of consent * Presenting with an acute ischaemic stroke for which symptoms (or last time seen as normal) are \< 24h * With occlusion of the ICA / the M1 segment of the MCA / a vertebral artery diameter ≥3.5mm / the basilar artery, defined by eTICI≤1 * Requiring endovascular treatment (mechanical thrombectomy) with or without intravenous thrombolysis * For whom the experimental device is the first-line treatment * Without pre-existing disability (mRS ≤3 and 6≤ NIHSS ≤30 before stroke) * Informed consent signed : * By the patient * Or consent by a family member/trusted support person if the patient's condition does not allow them to express their consent in writing (L1111-6) Exclusion Criteria: * Arterial dissection * Suspicion of vasculitis * Suspected intracranial stenosis near the occlusion site * Concomitant intracranial haemorrhage * Known coagulation disorder * Known coagulopathy * Known platelet count \<50,000/μL * Significant mass effect with midline shift * Suspicion or evidence of aortic dissection, septic embolus, or bacterial endocarditis * INR ≥ 3.0 * APTT ≥ 2 times normal * Systolic blood pressure \> 185 mmHg and/or diastolic blood pressure \< 110 mmHg * Blood glucose \< 50 mg/dL or \>400 mg/dL according to the last measurement taken before the procedure * Known allergy to contrast media * Occluded arteries in more than one large vascular territory (at least two of the left and right internal carotid arteries or the territory of a carotid artery and an artery of the vertebrobasilar system). * Pregnant or breast-feeding women (urine or serum pregnancy test negative at inclusion). * Adults under legal protection (L1121-8) * Persons deprived of their liberty by judicial or administrative decision, persons under psychiatric care under articles L3212-1 and L3123-1 and persons admitted to a health or social establishment for purposes other than research (L1121-6). * Participation in other interventional clinical research

Locations (1)

Hôpital Fondation Adolphe de Rothschild

Paris, France